Kura Oncology, Inc(NASDAQ:KURA) 
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. Its pipeline consists of small molecule product candidates that target cancer. The company's lead product candidates are tipifarnib, an orally bioavailable inhibitor ...
Website: http://www.kuraoncology.com
Founded: 2014
Full Time Employees: 83
CEO / Co-Founder: Troy Wilson
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.08
H 6.16
L 5.82
C 5.89
V 1,449,377
10EMA 5.89
20EMA 5.89
60EMA 5.89
120EMA 5.89
250EMA 5.89